You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Stage III NSCLC

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial (Atezolizumab, Tiragolumab)

Not yet recruiting
  • NSCLC
  • (no location specified)
Apr 5, 2023

Lung Cancer Stage III Trial (ctDNA)

Not yet recruiting
  • Lung Cancer Stage III
  • ctDNA
  • (no location specified)
Oct 26, 2023

NSCLC Trial in Changsha (Sugemalimab and Chemotherapy)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Sugemalimab and Chemotherapy
  • Changsha, China
    Hunan Cancer Hospital
Jul 7, 2023

Non Small Cell Lung Cancer, NSCLC, Stage III, Nsclc Trial in Stanford (Durvalumab, Carboplatin, Pemetrexed)

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
  • Stanford, California
    Stanford University
Oct 27, 2022

Lung Cancer, Nonsmall Cell, Lung Cancer Stage III Trial (combination product, drug, procedure, radiation)

Not yet recruiting
  • Lung Cancer, Nonsmall Cell
  • Lung Cancer Stage III
  • Nivolumab and Chemotherapy
  • +3 more
  • (no location specified)
Aug 15, 2023

Standard of Care Lifestyle Support for Stage III NSCLC Patients

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Lifestyle advice
  • (no location specified)
Aug 23, 2022

Lung Cancer Stage III Trial in New Brunswick (AN0025)

Not yet recruiting
  • Lung Cancer Stage III
  • Atlanta, Georgia
  • +1 more
Nov 2, 2022

Acute Side Effects In Stage III NSCLC With Definitive CRT

Completed
  • Non-small Cell Lung Cancer Stage III
    • Ankara, Turkey
      Ankara University Medicine School Radiation Oncology
    Aug 22, 2023

    Non Small Cell Lung Cancer Trial in Salt Lake City (radiation, device, drug)

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • carboplatin chemotherapy
    • +2 more
    • Salt Lake City, Utah
      Huntsman Cancer Institute
    Nov 3, 2023

    NSCLC Trial in Salvador, Belo Horizonte, São Paulo

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
      • Salvador, Bahia, Brazil
      • +3 more
      Nov 28, 2022

      Stage III NSCLC, Surgery Trial in Guangzhou (Lorlatinib)

      Not yet recruiting
      • Stage III NSCLC
      • Surgery
      • Guangzhou, Guangdong, China
        Guangdong Provincial People's Hospital
      Feb 21, 2023

      NSCLC Trial in Tianjing (Envalfolimab subcutaneously injected+Platinum-based doublet chemo intravenous injection,

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • Envalfolimab subcutaneously injected+Platinum-based doublet chemotherapy intravenous injection
      • placebo subcutaneously injected +Platinum-based doublet chemotherapy intravenous injection
      • Tianjing, Tianjin, China
        Tianjin cancer hospital
      Nov 3, 2023

      NSCLC, Stage III Trial in Chengdu (GFH018, Toripalimab, Paclitaxel)

      Not yet recruiting
      • NSCLC, Stage III
      • Chengdu, Sichuan, China
        West China Hospital, Sichuan University
      May 23, 2022

      Reveal Patterns of Presentation, Management and Outcome of SCLC

      Recruiting
      • Lung Cancer
        • Dammam, Saudi Arabia
        • +2 more
        Jul 25, 2022

        NSCLC, Stage III Trial (SHR-1701)

        Not yet recruiting
        • NSCLC, Stage III
        • (no location specified)
        Dec 14, 2021

        Stage III NSCLC RWE in Chinese Patients

        Active, not recruiting
        • Carcinoma, Non-Small-Cell Lung
          • BeiJing, China
          • +24 more
          Dec 14, 2022

          Non Small Cell Lung Cancer, Pancreatic Cancer, Colorectal Cancer Trial in United States (BMF-219)

          Recruiting
          • Non Small Cell Lung Cancer
          • +16 more
          • Goodyear, Arizona
          • +10 more
          Jan 24, 2023

          NSCLC Trial in Beijing

          Recruiting
          • NSCLC
            • Beijing, China
              Yuyan Wang
            Oct 10, 2023

            NSCLC, Stage III Trial in Beijing (Tislelizumab, Pemetrexed (Nonsquamous NSCLC) or Paclitaxel/Nab-paclitaxel(Squamous NSCLC),

            Recruiting
            • NSCLC, Stage III
            • Beijing, Beijing, China
              Beijing Tsinghua Chang Gung Hospital
            Nov 4, 2022

            NSCLC, Stage III Trial in Pavia (Durvalumab)

            Recruiting
            • NSCLC, Stage III
            • Pavia, Italy
              Fondazione IRCCS Policlinico San Matteo
            Nov 9, 2021

            NSCLC Stage III Trial in Paris, Milan, Barcelona (durvalumab plus platinum-based chemo (cisplatin or carboplatin plus

            Recruiting
            • Non-small Cell Lung Cancer Stage III
            • durvalumab plus platinum-based chemotherapy (cisplatin or carboplatin plus vinorelbine or pemetrexed)
            • +2 more
            • Paris, France
            • +2 more
            May 30, 2022

            Omitting Clinical Target Volume in Radical Treatment of

            Not yet recruiting
            • Immunotherapy
            • +3 more
            • IMRT+adjuvant immunotherapy
            • (no location specified)
            Jun 9, 2023

            NSCLC, Stage III Trial in Indianapolis (Signatera ctDNA test)

            Not yet recruiting
            • NSCLC, Stage III
            • Signatera ctDNA test
            • Indianapolis, Indiana
              Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
            Mar 13, 2023

            Stage III NSCLC Trial in Chengdu (Durvalumab, nanoparticle albumin bound paclitaxel, low dose radiation therapy)

            Recruiting
            • Stage III Non-small Cell Lung Cancer
            • Chengdu, Sichuan, China
              Sichuan Cancer Hospital
            Dec 2, 2021

            Response to Chemoradiation and Durvalumab in Stage III NSCLC.

            Recruiting
            • Lung Cancer
            • Lung Cancer Stage III
            • Pavia, Italy
              Fondazione IRCCS Policlinico San Matteo
            Oct 25, 2021